Anderson Hoagland & Co’s Bristol-Myers Squibb BMY Stock Holding History

Anderson Hoagland & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,426	Closed	-$4.17M	–	109
2021 Q3	$4.17M	Buy	70,426 +500	+0.7%	+$32.9K	0.53%	50
2021 Q2	$4.67M	Buy	69,926 +4,006	+6%	+$261K	0.59%	48
2021 Q1	$4.16M	Buy	65,920 +1,914	+3%	+$119K	0.59%	50
2020 Q4	$3.97M	Buy	64,006 +26,326	+70%	+$1.62M	0.63%	46
2020 Q3	$2.22M	Sell	37,680 -1,050	-3%	-$63.2K	1.06%	25
2020 Q2	$2.28M	Buy	38,730 +335	+0.9%	+$20K	1.07%	25
2020 Q1	$1.9M	Buy	38,395 +6,700	+21%	+$410K	1.17%	24
2019 Q4	$1.8M	Buy	+31,695	New	+$1.82M	1.02%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Anderson Hoagland & Co's BMY Position: Q4 2021 in Review

Anderson Hoagland & Co sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 70,426 shares — an estimated $4.17M sold.

Anderson Hoagland & Co first reported a position in BMY in Q4 2019 and held it in 8 quarters. The position peaked at $4.67M in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Anderson Hoagland & Co reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Anderson Hoagland & Co sold 70,426 Bristol-Myers Squibb shares in Q4 2021, an estimated $4.17M.
Anderson Hoagland & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 8 quarters.
Anderson Hoagland & Co's Bristol-Myers Squibb position peaked at $4.67M in Q2 2021.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Anderson Hoagland & Co's 13F filing for Q4 2021, filed 25 Jan 2022.